12:00 AM
Feb 12, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: α-hemolysin (aHL) Patent application filed; unavailable for licensing

Infectious disease

INDICATION: Bacterial infection

In vitro and mouse studies suggest a mAb against multiple Staphylococcus aureus hemolysin and leukocidin toxins could help treat bacterial infection. A yeast display screen of human antibodies identified a mAb that bound three...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >